Condition
Renal Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Renal Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (3), Italy (1)). By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Renal Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Neoadjuvant HIF-2α inhibitor with or without PD-1 antibody for resectable clear cell kidney cancer | Phase 2 | Boston, Massachusetts and 2 other locations | Recruiting | Feb 9, 2026 |
| R.E.C.K versus Exparel for pain control during robotic kidney removal | Phase 3 | Charlotte, North Carolina | Recruiting | Jul 30, 2025 |
| Comparing robotic platforms for kidney surgery outcomes | — | Verona, VR | Recruiting | Mar 4, 2024 |
| Olaparib treatment for patients with metastatic kidney cancer and specific gene mutations | Phase 2 | Baltimore, Maryland | Recruiting | Dec 26, 2018 |
All recruiting trials (4)
-
Neoadjuvant HIF-2α inhibitor with or without PD-1 antibody for resectable clear cell kidney cancer
This trial tests whether casdatifan alone or combined with zimberelimab can shrink tumors in people with resectable clear cell kidney cancer before surgery.
-
R.E.C.K versus Exparel for pain control during robotic kidney removal
This will test whether intraoperative R.E.C.K or Exparel gives better pain control and reduces opioid use in adults having robotic partial or radical nephrectomy.
-
Comparing robotic platforms for kidney surgery outcomes
This study is testing which robotic system, DaVinci or Hugo, works better for kidney surgery by looking at complications and outcomes for patients with localized kidney tumors.
-
Olaparib treatment for patients with metastatic kidney cancer and specific gene mutations
This study is testing if the oral medication olaparib can help people with advanced kidney cancer who have certain gene mutations and have already tried other treatments.
Related topics
Quick answers
How many Renal Carcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.